Human cytomegalovirus induces inhibition of macrophage differentiation by binding to human aminopeptidase N/CD13

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 4897-4907

  Gredmark, Sara ^a   Britt, William B ^b   Xie, Xun ^a   Lindbom, Lennart ^a   Söderberg Nauclér, Cecilia ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; ANTIBODY; ANTIBODY SJ1D1; ARPHAMENINE B; BESTATIN; CALCIUM; GLYCOPROTEIN GH; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MY7; MONOCLONAL ANTIBODY WM15; RECOMBINANT GLYCOPROTEIN GB; THAPSIGARGIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 6344229339     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.4897     Document Type: Article

References (57)

1. Britt, W. A. A., and C. A. Alford. 1996. Cytomegalovirus. In Fields Virology, Vol. 2. Lippincott-Raven Publishers, Philadelphia, p. 2493.
2. Speir, E., R. Modali, E. S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391.
3. Grattan, M. T., C. E. Moreno-Cabral, V. A. Starnes, P. E. Oyer, E. B. Stinson, and N. E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J. Am. Med. Assoc. 261:3561.
4. Lonnqvist, B., O. Ringden, B. Wahren, G. Gahrton, and G. Lundgren. 1984. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38:465.
5. Loenen, W. A., C. A. Bruggeman, and E. J. Wiertz. 2001. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 13:41.
6. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059.
7. Taylor-Wiedeman, J., G. P. Hayhurst, J. G. Sissons, and J. H. Sinclair. 1993. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 74:265.
8. Rice, G. P., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81:6134.
9. Einhorn, L., and A. Ost. 1984. Cytomegalovirus infection of human blood cells. J. Infect. Dis. 149:207.
10. Gnann, J. W., Jr., J. Ahlmen, C. Svalander, L. Olding, M. B. Oldstone, and J. A. Nelson. 1988. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pathol. 132:239.
11. Ibanez, C. E., R. Schrier, P. Ghazal, C. Wiley, and J. A. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:6581.
12. Fish, K. N., A. S. Depto, A. V. Moses, W. Britt, and J. A. Nelson. 1995. Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J. Virol. 69:3737.
13. + monocytes is differentiation dependent. J. Virol. 75:7543.
14. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597.
15. Söderberg-Nauclér, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119.
16. Söderberg-Nauclér, C., K. N. Fish, and J. A. Nelson. 1997. Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100:3154.
17. Stein, J., H. D. Volk, C. Liebenthal, D. H. Kruger, and S. Prosch. 1993. Tumour necrosis factor α stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74:2333.
18. Prosch, S., A. K. Heine, H. D. Volk, and D. H. Kruger. 2001. CCAAT/enhancer-binding proteins α and β negatively influence the capacity of tumor necrosis factor α to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor κB during monocyte differentiation. J. Biol. Chem. 276:40712.
19. Ritter, T., C. Brandt, S. Prosch, A. Vergopoulos, K. Vogt, J. Kolls, and H. D. Volk. 2000. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine 12:1163.
20. Prosch, S., K. Staak, J. Stein, C. Liebenthal, T. Stamminger, H. D. Volk, and D. H. Kruger. 1995. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFα is mediated via induction of NF-κB. Virology 208:197.
21. Sindre, H., G. E. Tjoonnfjord, H. Rollag, T. Ranneberg-Nilsen, O. P. Veiby, S. Beck, M. Degre, and K. Hestdal. 1996. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88:4526.
22. + bone marrow progenitors. J. Gen. Virol. 77:3099.
23. + cells from blood and bone marrow. Blood 86:4086.
24. + progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 88:1277.
25. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017.
26. Kondo, K., and E. S. Mocarski. 1995. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J. Infect. Dis. 99(Suppl.):63.
27. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95:3937.
28. Gredmark, S., T. Tilburgs, and C. Söderberg-Nauclér. 2004. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J. Virol. 78:19.
29. Fortunato, E. A., A. K. McElroy, I. Sanchez, and D. H. Spector. 2000. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 8:111.
30. Söderberg, C., T. D. Giugni, J. A. Zaia, S. Larsson, J. M. Wahlberg, and E. Möller. 1993. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J. Virol. 67:6576.
31. Söderberg, C., S. Larsson, S. Bergstedt-Lindqvist, and E. Möller. 1993. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J. Virol. 67:3166.
32. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253.
33. Ashmun, R. A., and A. T. Look. 1990. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 75:462.
34. Spaete, R. R. 1991. A recombinant subunit vaccine approach to HCMV vaccine development. Transplant Proc. 23:90.
35. Favaloro, E. J. 1991. CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity. Immunol. Cell Biol. 69:253.
36. Lytton, J., M. Westlin, and M. R. Hanley. 1991. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 266:17067.
37. Riemann, D., A. Kehlen, and J. Langner. 1999. CD13-not just a marker in leukemia typing. Immunol. Today 20:83.
38. + cells. Blood 95:453.
39. Sweet, C. 1999. The pathogenicity of cytomegalovirus. FEMS Microbiol. Rev. 23:457.
40. Zhu, H., J. P. Cong, G. Mamtora, T. Gingeras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:14470.
41. Boyle, K. A., R. L. Pietropaolo, and T. Compton. 1999. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:3607.
42. Simmen, K. A., J. Singh, B. G. Luukkonen, M. Lopper, A. Bittner, N. E. Miller, M. R. Jackson, T. Compton, and K. Fruh. 2001. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. USA 98:7140.
43. Yurochko, A. D., and E. S. Huang. 1999. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162:4806.
44. Johnson, R. A., X. Wang, X. L. Ma, S. M. Huong, and E. S. Huang. 2001. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75:6022.
45. Johnson, R. A., S. M. Huong, and E. S. Huang. 2000. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 74:1158.
46. 2+ responses in cytomegaiovirus-infected fibroblasts of human origin. Virology 157:259.
47. Lohn, M., C. Mueller, K. Thiele, T. Kahne, D. Riemann, and J. Langner. 1997. Aminopeptidase N-mediated signal transduction and inhibition of proliferation of human myeloid cells. Adv. Exp. Med. Biol. 421:85.
48. Santos, A. N., J. Langner, M. Herrmann, and D. Riemann. 2000. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell. Immunol. 201:22.
49. Valledor, A. F., F. E. Borras, M. Cullell-Young, and A. Celada. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukocyte Biol. 63:405.
50. Gonczol, E., P. W. Andrews, and S. A. Plotkin. 1984. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science 224:159.
51. Smith, M. S., G. L. Bentz, J. S. Alexander, and A. D. Yurochko. 2004. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78:4444.
52. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA 93:11137.
53. White, K. L., B. Slobedman, and E. S. Mocarski. 2000. Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J. Virol. 74:9333.
54. Mutimer, D., D. Mirza, J. Shaw, K. O'Donnell, and E. Elias. 1997. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 63:1411.
55. van den Berg, A. P., I. J. Klompmaker, E. B. Haagsma, P. M. Peeters, L. Meerman, R. Verwer, T. H. The, and M. J. Slooff. 1996. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin. Transplant. 10:224.
56. Paya, C. V., R. H. Wiesner, P. E. Hermans, J. J. Larson-Keller, D. M. Ilstrup, R. A. Krom, S. Rettke, and T. F. Smith. 1993. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J. Hepatol. 18:185.
57. Gredmark, S., and C. Söderberg-Nauclér. 2003. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J. Virol. 77:10943.